Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA (FSNUF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fsnuf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Fresenius SE & Co. KGaA (FSNUF) measures how much investors pay for each dollar of the company's trailing earnings. FSNUF's current PE ratio of 14.09x is calculated by dividing its stock price of $57.00 by its TTM earnings per share of $2.62. −11.7% discount vs 5Y avg 16.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%19.8x
MedianQ3 · 75%147.4x
Max
At 14.09x, FSNUF's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Fresenius SE & Co. KGaAYou FSNUF | $32.1B | 14.09x | -32.3% | $2.62 |
 Bayer AG BAYRY | $40.1B | N/A | — | -$0.88 |
 Fresenius Medical Care AG & Co. KGaA FMCQF | $11.6B | 11.79x | -43.3% | $3.36 |
 JD Health International Inc. JDHIF | $18.7B | 32.02x | +53.9% | $1.66 |
 Wellbeing Digital Sciences Inc. KONEF | $0M | N/A | — | -$0.21 |
 Otsuka Holdings Co., Ltd. OTSKY | $34.9B | 12.37x | -40.5% | $359.14 |
 ResMed Inc. RSMDF | $29.1B | 27.02x | +29.9% | $9.55 |
Industry Average 4 peers with valid PE | — | 20.80x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 21.21x | $2.24 | -44.1% | |
2024-12-31 FY2024 | 37.94x | $0.84 | — | |
2023-12-31 FY2023 | — | $-1.06 | — | |
2022-12-31 FY2022 | 6.67x | $3.77 | -2.6% | |
2021-12-31 FY2021 | 6.85x | $5.05 | -3.9% | |
2020-12-31 FY2020 | 7.12x | $5.06 | -22.3% | |
2019-12-31 FY2019 | 9.17x | $5.44 | -14.9% | |
2018-12-31 FY2018 | 10.78x | $3.65 | -45.5% | |
2017-12-31 FY2017 | 19.76x | $3.27 | -19.5% | |
2016-12-31 FY2016 | 24.54x | $2.91 | -7.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Fresenius SE & Co. KGaA (FSNUF) measures how much investors pay for each dollar of the company's trailing earnings. FSNUF's current PE ratio of 14.09x is calculated by dividing its stock price of $57.00 by its TTM earnings per share of $2.62.
Frequently asked questions
FSNUF pe ratio · 6 questionsFSNUF's current PE ratio is 14.09x as of 2026-06-08, based on a stock price of $57.00 and TTM EPS of $2.62. Data sourced from Financial Modeling Prep via FSNUF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fresenius SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08